136 related articles for article (PubMed ID: 3018695)
61. Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells.
Gardner JD; Conlon TP; Fink ML; Bodanszky M
Gastroenterology; 1976 Dec; 71(6):965-70. PubMed ID: 186350
[TBL] [Abstract][Full Text] [Related]
62. Somatostatin rapidly restores rat growth hormone (GH) release response attenuated by prior exposure to human GH-releasing factor in vitro.
Soya H; Suzuki M
Endocrinology; 1988 Jun; 122(6):2492-8. PubMed ID: 2897284
[TBL] [Abstract][Full Text] [Related]
63. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin.
Nowak JZ; Kuba K
J Mol Neurosci; 2002; 18(1-2):47-52. PubMed ID: 11931349
[TBL] [Abstract][Full Text] [Related]
64. Evidence for a cyclic AMP system highly sensitive to secretin in gastric glands isolated from the rat fundus and antrum.
Gespach C; Bataille D; Dupont C; Rosselin G; Wünsch E; Jaeger E
Biochim Biophys Acta; 1980 Jul; 630(3):433-41. PubMed ID: 6249385
[TBL] [Abstract][Full Text] [Related]
65. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone.
Huang M; Rorstad OP
J Neurochem; 1984 Sep; 43(3):849-56. PubMed ID: 6086840
[TBL] [Abstract][Full Text] [Related]
66. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
Westendorf JM; Schonbrunn A
Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
[TBL] [Abstract][Full Text] [Related]
67. GRF is a highly potent activator of adenylate cyclase in the normal human, bovine and rat pituitary: interaction with somatostatin.
Reyl-Desmars F; Baird A; Zeytin FN
Biochem Biophys Res Commun; 1985 Mar; 127(3):977-85. PubMed ID: 2859017
[TBL] [Abstract][Full Text] [Related]
68. Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism.
Wiik P
Regul Pept; 1989 May; 25(2):187-97. PubMed ID: 2474178
[TBL] [Abstract][Full Text] [Related]
69. Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function.
Ciampani T; Fabbri A; Isidori A; Dufau ML
Endocrinology; 1992 Dec; 131(6):2785-92. PubMed ID: 1332849
[TBL] [Abstract][Full Text] [Related]
70. Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse.
Hyde JF; Morrison DG; Drake KW; Moore JP; Maley BE
J Neuroendocrinol; 1996 Jan; 8(1):9-15. PubMed ID: 8932732
[TBL] [Abstract][Full Text] [Related]
71. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion.
Stachura ME; Tyler JM; Farmer PK
Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135
[TBL] [Abstract][Full Text] [Related]
72. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
73. Regulation by secretin, vasoactive intestinal peptide, and somatostatin of cyclic AMP accumulation in cultured brain cells.
van Calker D; Müller M; Hamprecht B
Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6907-11. PubMed ID: 6109286
[TBL] [Abstract][Full Text] [Related]
74. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
Cunha SR; Mayo KE
Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
[TBL] [Abstract][Full Text] [Related]
75. Receptors involved in helodermin action on rat pancreatic acini.
Dehaye JP; Winand J; Damien C; Gomez F; Poloczek P; Robberecht P; Vandermeers A; Vandermeers-Piret MC; Stiévenart M; Christophe J
Am J Physiol; 1986 Nov; 251(5 Pt 1):G602-10. PubMed ID: 2430470
[TBL] [Abstract][Full Text] [Related]
76. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3':5'-monophosphate.
Robberecht P; Conlon TP; Gardner JD
J Biol Chem; 1976 Aug; 251(15):4635-9. PubMed ID: 181379
[TBL] [Abstract][Full Text] [Related]
77. Secretin and VIP-stimulated adenylate cyclase from rat heart. II. Impairment in spontaneous hypertension.
Chatelain P; Robberecht P; De Neef P; Camus JC; Heuse D; Christophe J
Pflugers Arch; 1980 Dec; 389(1):29-35. PubMed ID: 7193464
[TBL] [Abstract][Full Text] [Related]
78. Effect of the peptide PHI-27 on prolactin release in vitro.
Werner S; Hulting AL; Hökfelt T; Eneroth P; Tatemoto K; Mutt V; Maroder L; Wünsch E
Neuroendocrinology; 1983 Dec; 37(6):476-8. PubMed ID: 6657006
[TBL] [Abstract][Full Text] [Related]
79. VIP regulation of a human pancreatic cancer cell line: Capan-1.
Ruellan C; Scemama JL; Clerc P; Fagot-Revurat P; Clemente F; Ribet A
Peptides; 1986; 7 Suppl 1():267-71. PubMed ID: 3018700
[TBL] [Abstract][Full Text] [Related]
80. Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes.
Sorg O; Magistretti PJ
Brain Res; 1991 Nov; 563(1-2):227-33. PubMed ID: 1664773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
